Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anagnou, Nicholas P."'
Autor:
Yannaki E; Hematology Department-HCT Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Psatha N; Altius Institute for Biomedical Sciences, Seattle, Washington, USA., Papadopoulou A; Hematology Department-HCT Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Athanasopoulos T; Cell and Gene Therapy (CGT), Medicinal Science and Technology (MST), GlaxoSmithKline (GSK), Medicines Research Centre, Stevenage, United Kingdom., Gravanis A; Department of Pharmacology, School of Medicine, University of Crete, Heraklion, Greece., Roubelakis MG; Laboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece and Centre of Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece., Tsirigotis P; 2nd Department of Internal Medicine, ATTIKO General University Hospital, National and Kapodistrian University of Athens, Athens, Greece., Anagnostopoulos A; Hematology Department-HCT Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Anagnou NP; BRFAA, Cell and Gene Therapy Lab, Athens, Greece., Vassilopoulos G; BRFAA, Cell and Gene Therapy Lab, Athens, Greece.; Department of Hematology, UHL, University of Thessaly Medical School, Athens, Greece.
Publikováno v:
Human gene therapy [Hum Gene Ther] 2021 Oct; Vol. 32 (19-20), pp. 1120-1137.
Autor:
Drakopoulou E; 1 Laboratory of Cell and Gene Therapy, Centre for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.; 2 Laboratory of Biology, University of Athens School of Medicine, Athens, Greece., Georgomanoli M; 1 Laboratory of Cell and Gene Therapy, Centre for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.; 2 Laboratory of Biology, University of Athens School of Medicine, Athens, Greece., Lederer CW; 3 Department of Molecular Genetics Thalassemia, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; 4 Cyprus School of Molecular Medicine, Nicosia, Cyprus., Kleanthous M; 3 Department of Molecular Genetics Thalassemia, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.; 4 Cyprus School of Molecular Medicine, Nicosia, Cyprus., Costa C; 5 CIRI-International Center for Infectiology Research, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR 5308, Ecole Normale Supérieure de Lyon, Lyon, France., Bernadin O; 5 CIRI-International Center for Infectiology Research, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR 5308, Ecole Normale Supérieure de Lyon, Lyon, France., Cosset FL; 5 CIRI-International Center for Infectiology Research, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR 5308, Ecole Normale Supérieure de Lyon, Lyon, France., Voskaridou E; 6 Thalassemia and Sickle Cell Disease Centre, Laikon General Hospital, Athens, Greece., Verhoeyen E; 5 CIRI-International Center for Infectiology Research, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR 5308, Ecole Normale Supérieure de Lyon, Lyon, France.; 7 Inserm, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), Equipe Contrôle Métabolique des Morts Cellulaires, Nice, France., Papanikolaou E; 1 Laboratory of Cell and Gene Therapy, Centre for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.; 2 Laboratory of Biology, University of Athens School of Medicine, Athens, Greece., Anagnou NP; 1 Laboratory of Cell and Gene Therapy, Centre for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.; 2 Laboratory of Biology, University of Athens School of Medicine, Athens, Greece.
Publikováno v:
Human gene therapy [Hum Gene Ther] 2019 May; Vol. 30 (5), pp. 601-617. Date of Electronic Publication: 2019 Mar 15.
Autor:
Büning H; 1 European Society of Gene and Cell Therapy (ESGCT)., Griesenbach U; 2 British Society for Gene and Cell Therapy (BSGCT)., Fehse B; 3 Deutsche Gesellschaft für Gentherapie (DG-GT)., Ylä-Herttuala S; 4 Finnish Society of Gene Therapy (FSGT)., Anagnou NP; 5 Hellenic Society of Gene Therapy and Regenerative Medicine (HSGTRM)., van Beusechem V; 6 Netherlands Society for Gene & Cell Therapy (NVGCT) ., Raya A; 7 Sociedad Española de Terapia Génica y Celular (SETGyC)., Verhoeyen E; 8 Société Française de Thérapie Cellulaire et Génique (SFTCG) .
Publikováno v:
Human gene therapy [Hum Gene Ther] 2018 Dec; Vol. 29 (12), pp. 1337-1338. Date of Electronic Publication: 2018 Dec 04.
Autor:
Papanikolaou E; Laboratory of Cell and Gene Therapy, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA) , 11527 Athens, Greece., Georgomanoli M, Stamateris E, Panetsos F, Karagiorga M, Tsaftaridis P, Graphakos S, Anagnou NP
Publikováno v:
Human gene therapy [Hum Gene Ther] 2012 Jan; Vol. 23 (1), pp. 15-31. Date of Electronic Publication: 2011 Dec 05.